Medigen Biotechnology Statistics

Total Valuation

TPEX:3176 has a market cap or net worth of TWD 4.44 billion. The enterprise value is 6.33 billion.

Market Cap	4.44B
Enterprise Value	6.33B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:3176 has 139.31 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	n/a
Shares Outstanding	139.31M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	6.56%
Owned by Institutions (%)	4.26%
Float	109.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.24
PB Ratio	2.81
P/TBV Ratio	3.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.93
EV / Sales	4.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-373.99

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.20.

Current Ratio	3.96
Quick Ratio	3.20
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	-60.17
Interest Coverage	-5.97

Financial Efficiency

Return on equity (ROE) is -4.43% and return on invested capital (ROIC) is -1.95%.

Return on Equity (ROE)	-4.43%
Return on Assets (ROA)	-1.78%
Return on Invested Capital (ROIC)	-1.95%
Return on Capital Employed (ROCE)	-3.75%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.18
Inventory Turnover	1.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.65% in the last 52 weeks. The beta is 0.55, so TPEX:3176's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-19.65%
50-Day Moving Average	34.80
200-Day Moving Average	37.15
Relative Strength Index (RSI)	30.36
Average Volume (20 Days)	136,259

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:3176 had revenue of TWD 1.37 billion and -204.69 million in losses. Loss per share was -1.47.

Revenue	1.37B
Gross Profit	753.76M
Operating Income	-217.20M
Pretax Income	-112.72M
Net Income	-204.69M
EBITDA	-66.30M
EBIT	-217.20M
Loss Per Share	-1.47

Full Income Statement

Balance Sheet

The company has 2.59 billion in cash and 1.02 billion in debt, giving a net cash position of 1.57 billion or 11.27 per share.

Cash & Cash Equivalents	2.59B
Total Debt	1.02B
Net Cash	1.57B
Net Cash Per Share	11.27
Equity (Book Value)	5.04B
Book Value Per Share	11.36
Working Capital	2.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.92 million and capital expenditures -54.85 million, giving a free cash flow of -16.93 million.

Operating Cash Flow	37.92M
Capital Expenditures	-54.85M
Free Cash Flow	-16.93M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross margin is 54.91%, with operating and profit margins of -15.82% and -14.91%.

Gross Margin	54.91%
Operating Margin	-15.82%
Pretax Margin	-8.21%
Profit Margin	-14.91%
EBITDA Margin	-4.83%
EBIT Margin	-15.82%
FCF Margin	n/a

Dividends & Yields

TPEX:3176 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.03%
Shareholder Yield	0.03%
Earnings Yield	-4.61%
FCF Yield	-0.38%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:3176 has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	n/a